The effect of Huashibaidu formula on the blood oxygen saturation status of severe COVID-19: A retrospective cohort study

BACKGROUND: Huashibaidu Formula (HSBD) for the COVID-19 treatment has been supported by the China's Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia. However, it is not clear whether HSBD can improve blood oxygen saturation and when it should be used with conventional therapies....

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Yibai, Tian, Yaxin, Ma, Yan, Liu, Bin, Ruan, Lianguo, Lu, Cheng, Huang, Luqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier GmbH. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641428/
https://www.ncbi.nlm.nih.gov/pubmed/34929564
http://dx.doi.org/10.1016/j.phymed.2021.153868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641428/
https://www.ncbi.nlm.nih.gov/pubmed/34929564
http://dx.doi.org/10.1016/j.phymed.2021.153868

Ejemplares similares